Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised studySue Ann Costa Clemens, Laiana Januse de Arruda Cordeiro Matos, Mayara Fraga et al.|The Lancet|2022Cited by 467
Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trialMarcelo Augusto Duarte Silveira, Rogério da Hora Passos, David De Jong et al.|Biomedicine & Pharmacotherapy|2021Cited by 121
Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trialMarcelo Augusto Duarte Silveira, David De Jong, Erica Batista dos Santos Galvão et al.|medRxiv|2021Cited by 14
Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trialMarcelo Augusto Duarte Silveira, Rogério da Hora Passos, Matheus de Alencar Menezes et al.|Scientific Reports|2023Cited by 8
Differential impact of on-site or telepharmacy in the intensive care unit: a controlled before–after studyJoão Gabriel Rosa Ramos, Ana Verena Almeida Mendes, Sandra Cristina Hernandes et al.|International Journal for Quality in Health Care|2021Cited by 6